Video-On-Demand
(Available until 31 March 2023)
On-Demand Videos are no longer available after 31 March 2023. Thanks for your kind attention.
Deadline for Abstract Submission:
19 September 2022
Deadline for Early-Bird Registration:
19 October 2022

Speakers

Dr. Yu Lin WONG
Director/ Senior Consultant
Neuro Intensive Care Unit/ Tan Tock Seng Hospital
Singapore


After my basic MBBS degree, I am dually accredited for anaesthesia (MMed Anaesthesia Singapore) and (ANZCA Australia). followed by Intensive Care Medicine Subspecialty accreditation (ICM Singapore).

I am currently the NICU director in Tan Tock Seng Hospital, as well as chair the hospital Brain death Workgroup and Organ Transplant Improvement Programme.

I have an interest in sedation and delirium in ICU and Palliative care in ICU.

I have had research grants for ICU projects including ICU diary, virtual reality rehabilitation in ICU, palliative care in ICU, and non verbal communication tools in ICU. Currently, we will be embarking on Platelet mapping studies for NICU patients on antiplatelet therapy who present with ICH.

Publications include Singapore SPICE: sedation practices in ICU evaluation in Singapore, Sedation Intensity in the first 48 hours of mechanical Ventilation, Integrating Palliative Care in Neurosurgical ICU, Physiological Changes during Prone posiyioning in COVID-19 Acute respiratory Distress syndrome, challenges in adapting exisiting hyperacute stroke protocols in Singapore for COVID-19.


Abstract
Managing Neurological Emergencies during the Coronavirus Pandemic

Since the start of the Coronavirus pandemic, there has been an excess of more than 600 million infections and more than 6 million deaths worldwide. Approximately 2% of COVID-19 patients present with neurological symptoms. Neurological complications are also common in hospitalized COVID-19 patients.

Intracerebral haemorrhage and acute ischaemic strokes are acute and common complications of COVID-19. Time is of the essence and concomitant COVID-19 infections in these patients present challenges and requires modification to our usual hyperacute stroke care pathways.

We will discuss our Singapore experience dealing with acute stroke care in a Tertiary Neuroscience Centre and the National Centre for Infectious Disease.

 

back